Ovid Therapeutics Inc. (OVID) stock
OVIDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$2.26+0.04 (+1.80%)
Close on Nov 18, 2026Market cap $441.37MP/E –Yield –
Ovid Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Ovid Therapeutics's market cap was $513.62M on Nov 11, 2026, against $126.65M a year earlier. Over the last 5 years it ranged from $19.36M to $513.62M, with a median of $181.80M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $513.62M | +342.9% |
| 2025 | Dec 31, 2025 | $115.98M | +74.9% |
| 2024 | Dec 31, 2024 | $66.30M | -70.9% |
| 2023 | Dec 29, 2023 | $227.59M | +73.6% |
| 2022 | Dec 30, 2022 | $131.07M | -40.0% |
| 2021 | Dec 31, 2021 | $218.33M | +49.0% |
| 2020 | Dec 31, 2020 | $146.54M | -5.8% |
| 2019 | Dec 31, 2019 | $155.49M | +160.6% |
| 2018 | Dec 31, 2018 | $59.66M | -75.4% |
| 2017 | Dec 29, 2017 | $242.82M | – |
See a number that looks wrong?